Cover Image

The management of low-stage non-seminomatous germ cell tumors

Louise Lim, Thomas Powles
  • Louise Lim
    Department of Medical Oncology, Barts Cancer Institute, QMUL, Experimantal Cancer Med St. Bartholomew’s Hospital London, United Kingdom | FarahLouise.Lim@bartshealth.nhs.uk
  • Thomas Powles
    Department of Medical Oncology, Barts Cancer Institute, QMUL, Experimantal Cancer Med St. Bartholomew’s Hospital London, United Kingdom

Abstract

The prognosis of patients with stage I non-seminomatous germ cell tumors is in general very good. However, a large number of patients relapse with metastatic disease after orchidectomy Therefore, adjuvant treatment, in the form of either chemotherapy or retroperitoneal dissection is recommended, although active surveillance has been found to be as good a way of treating these patients with overall excellent results.

Keywords

non-seminomatous germ cell cancer, surveillance, adjuvant therapy.

Full Text:

PDF
HTML
Submitted: 2012-04-27 19:16:45
Published: 2012-10-08 16:47:34
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
2178

Views:
PDF
268
HTML
274

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2012 Louise Lim, Thomas Powles

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185